Oxycodone and Acetaminophen Recall: SpecGx 7.5/325
Announced 2026-01-14 · FDA
The recall covers SpecGx LLC Oxycodone and Acetaminophen CII tablets, 7.5 mg/325 mg, Rx only, in 100-count bottles (NDC 0406-0522-01), Lot 0522J23493, Exp 03/2027, distributed nationwide, affecting 74,544 bottles. The recall is due to a potential for the imprint to be missing on tablets.
| Brand | SpecGx, LLC |
|---|---|
| Product | Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493 |
| Reason | Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. |
| Severity | moderate |
| Units affected | 287988 |
| Distribution | Nationwide |
| Agency | FDA |
| Recall / campaign no. | Lot: 0522J23493, expires: 03/2027. |
WHAT YOU SHOULD DO
- Do not take or use this medication.
- Check your bottle for Lot 0522J23493 and expiration 03/2027; if matched, set aside and do not consume.
- Contact your pharmacist or healthcare provider for guidance and possible replacement.
- Follow local disposal instructions for recalled medicines.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.